Interpace Biosciences, Inc. Share Price
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.630 USD | +1.24% |
|
-0.61% | +32.50% |
| Market Cap | 4.52Cr 3.95Cr 3.62Cr 3.38Cr 6.41Cr 429.85Cr 6.51Cr 44Cr 17Cr 210.84Cr 17Cr 17Cr 726.49Cr | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 4.38Cr 3.83Cr 3.52Cr 3.28Cr 6.22Cr 417.27Cr 6.32Cr 42Cr 16Cr 204.67Cr 16Cr 16Cr 705.22Cr | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.24% | ||
| 1 week | -0.61% | ||
| 1 month | -7.39% | ||
| 3 months | -16.73% | ||
| 6 months | +36.97% | ||
| Current year | +32.50% |
| 1 week | 1.6 |  | 1.8 |
| 1 month | 1.57 | | 1.8 |
| Current year | 1.03 | | 2.4 |
| 1 year | 0.76 | | 2.4 |
| 3 years | 0.44 | | 3.54 |
| 5 years | 0.44 | | 10.5 |
| 10 years | 0.44 | | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 63 | 01/12/2020 |
| Director of Finance/CFO | 34 | 21/04/2023 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 78 | 21/06/2016 |
Joseph Keegan
BRD | Director/Board Member | 73 | 01/01/2016 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 22/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/01 | Ampersand Management LLC
| Conversion | Company | 1,38,61,386 | 313.0013% | |
| 20/01 | 1315 Capital LLC
| Conversion | Company | 94,05,941 | 212.3938% | |
| 01/24/01 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.24% | -0.61% | +112.96% | +48.18% | 4.52Cr | |
| +1.10% | +7.13% | +72.88% | +474.02% | 4TCr | |
| +1.09% | +7.75% | +10.38% | +18.92% | 2.35TCr | |
| +1.58% | +4.06% | -20.86% | -40.58% | 716.55Cr | |
| +4.77% | +14.56% | +23.54% | +110.76% | 540.61Cr | |
| -1.35% | -1.28% | +17.97% | +44.33% | 289.82Cr | |
| -5.86% | -1.69% | -24.81% | +1,032.72% | 200.42Cr | |
| +1.27% | +10.42% | +104.86% | -5.66% | 197.4Cr | |
| -0.93% | +2.42% | +37.60% | -20.76% | 182.72Cr | |
| +1.94% | +2.14% | +20.92% | -1.68% | 164.93Cr | |
| Average | +0.47% | +4.02% | +35.54% | +166.03% | 865.05Cr | |
| Weighted average by Cap. | +1.10% | +6.66% | +39.94% | +252.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.69Cr 4.1Cr 3.77Cr 3.51Cr 6.66Cr 446.74Cr 6.77Cr 45Cr 18Cr 219.12Cr 18Cr 17Cr 755.03Cr | 3.87Cr 3.38Cr 3.11Cr 2.9Cr 5.49Cr 368.69Cr 5.59Cr 37Cr 15Cr 180.84Cr 15Cr 14Cr 623.12Cr |
| Net income | 67.02L 58.56L 53.78L 50.15L 95.07L 64Cr 96.68L 6.47Cr 2.51Cr 31Cr 2.52Cr 2.46Cr 107.83Cr | 2.46Cr 2.15Cr 1.97Cr 1.84Cr 3.49Cr 233.95Cr 3.54Cr 24Cr 9.2Cr 114.75Cr 9.23Cr 9.03Cr 395.4Cr |
| Net Debt | 43.95L 38.4L 35.27L 32.89L 62.35L 42Cr 63.4L 4.25Cr 1.65Cr 21Cr 1.65Cr 1.61Cr 71Cr | -13.22L -11.55L -10.61L -10L -18.75L -13Cr -19.07L -1.28Cr -49.5L -6.17Cr -49.64L -48.56L -21Cr |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $1.630 | +1.24% | 1,100 |
| 01/26/01 | $1.610 | -1.23% | 2,190 |
| 30/26/30 | $1.630 | -2.98% | 16,175 |
| 29/26/29 | $1.680 | +1.82% | 2,403 |
| 26/26/26 | $1.650 | +0.61% | 2,333 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
